GLMD vs. VYM
GLMD (Galmed Pharmaceuticals Ltd.) is a stock, while VYM (Vanguard High Dividend Yield ETF) is Dividend fund tracking the FTSE High Dividend Yield Index. Over the past 10 years, GLMD returned -51.30%/yr vs 12.19%/yr for VYM. At a 0.16 correlation, their price movements are largely independent.
Performance
GLMD vs. VYM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GLMD achieves a -23.58% return, which is significantly lower than VYM's 12.09% return. Over the past 10 years, GLMD has underperformed VYM with an annualized return of -51.30%, while VYM has yielded a comparatively higher 12.19% annualized return.
GLMD
- 1D
- -2.38%
- 1M
- -8.97%
- YTD
- -23.58%
- 6M
- -34.85%
- 1Y
- -68.31%
- 3Y*
- -75.72%
- 5Y*
- -74.81%
- 10Y*
- -51.30%
VYM
- 1D
- 0.61%
- 1M
- 0.79%
- YTD
- 12.09%
- 6M
- 10.90%
- 1Y
- 24.37%
- 3Y*
- 18.41%
- 5Y*
- 11.86%
- 10Y*
- 12.19%
GLMD vs. VYM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GLMD Galmed Pharmaceuticals Ltd. | -23.58% | -76.47% | -41.58% | -93.93% | -72.53% | -41.48% | -46.19% | -15.37% | -25.36% | 160.68% |
VYM Vanguard High Dividend Yield ETF | 12.09% | 15.42% | 17.60% | 6.57% | -0.43% | 26.20% | 1.15% | 24.06% | -5.92% | 16.42% |
Correlation
The correlation between GLMD and VYM is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Mar 13, 2014 | 0.16 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GLMD vs. VYM — Risk / Return Rank
GLMD
VYM
GLMD vs. VYM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Galmed Pharmaceuticals Ltd. (GLMD) and Vanguard High Dividend Yield ETF (VYM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GLMD | VYM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.10 | ||
| Sortino ratioReturn per unit of downside risk | -4.42 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 1.43 | -0.56 |
| Calmar ratioReturn relative to maximum drawdown | -0.86 | 3.66 | -4.51 |
| Martin ratioReturn relative to average drawdown | -1.17 | 13.57 | -14.74 |
Loading charts...
Drawdowns
GLMD vs. VYM - Drawdown Comparison
The maximum GLMD drawdown since its inception was -99.99%, which is greater than VYM's maximum drawdown of -56.98%. Use the drawdown chart below to compare losses from any high point for GLMD and VYM.
Loading charts...
Drawdown Indicators
| GLMD | VYM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -56.98% | -43.01% |
Max Drawdown (1Y)Largest decline over 1 year | -79.86% | -6.69% | -73.17% |
Max Drawdown (3Y)Largest decline over 3 years | -98.77% | -14.46% | -84.31% |
Max Drawdown (5Y)Largest decline over 5 years | -99.92% | -15.84% | -84.08% |
Max Drawdown (10Y)Largest decline over 10 years | -99.99% | -35.21% | -64.78% |
Current DrawdownCurrent decline from peak | -99.98% | -0.77% | -99.21% |
Average DrawdownAverage peak-to-trough decline | -76.08% | -7.17% | -68.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 58.40% | 1.80% | +56.60% |
Volatility
GLMD vs. VYM - Volatility Comparison
Galmed Pharmaceuticals Ltd. (GLMD) has a higher volatility of 48.77% compared to Vanguard High Dividend Yield ETF (VYM) at 2.95%. This indicates that GLMD's price experiences larger fluctuations and is considered to be riskier than VYM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GLMD | VYM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 48.77% | 2.95% | +45.82% |
Volatility (6M)Calculated over the trailing 6-month period | 73.85% | 7.64% | +66.21% |
Volatility (1Y)Calculated over the trailing 1-year period | 93.39% | 10.36% | +83.03% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 166.70% | 13.93% | +152.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 138.11% | 16.31% | +121.80% |
Dividends
GLMD vs. VYM - Dividend Comparison
GLMD has not paid dividends to shareholders, while VYM's dividend yield for the trailing twelve months is around 2.28%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GLMD Galmed Pharmaceuticals Ltd. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VYM Vanguard High Dividend Yield ETF | 2.28% | 2.44% | 2.74% | 3.12% | 3.01% | 2.76% | 3.18% | 3.03% | 3.40% | 2.80% | 2.91% | 3.22% |
Frequently Asked Questions
GLMD and VYM have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GLMD has higher volatility (48.77%) compared to VYM (2.95%). In terms of maximum drawdown, GLMD dropped -99.99% vs VYM's -56.98%.
VYM currently has the higher Sharpe Ratio (2.37 vs -0.73), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GLMD and VYM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer